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Abstract
Background:  Transcriptional transactivation is a process with remarkable tolerance for sequence
diversity and structural geometry. In studies of the features that constitute transactivating
functions, acidity has remained one of the most common characteristics observed among native
activation domains and activator peptides.
Results:  We performed a deliberate search of random peptide libraries for peptides capable of
conferring transcriptional transactivation on the lexA DNA binding domain. Two libraries, one
composed of C-terminal fusions, the other of peptide insertions within the green fluorescent
protein structure, were used. We show that (i) peptide sequences other than C-terminal fusions
can confer transactivation; (ii) though acidic activator peptides are more common, charge neutral
and basic peptides can function as activators; and (iii) peptides as short as 11 amino acids behave in
a modular fashion.
Conclusions:  These results support the recruitment model of transcriptional activation and,
combined with other studies, suggest the possibility of using activator peptides in a variety of
applications, including drug development work.
Introduction
Transcriptional activation is one of the key elements of
eukaryotic gene expression. A variety of genetic, bio-
chemical, and structural studies have revealed many
mechanistic details of this process [see, for review, [1–
3]]. In some cases, the structural/chemical basis for pro-
tein/DNA complex formation and recruitment of ancil-
lary factors that promote transcription have been
elucidated. Mutational analysis has defined regions of
transcription factors – even specific residues – that par-
ticipate in the activation process [4–9]. One of the most
common structural features is the acidic activation do-
main, a region with excess negative charge present on
many native activators as well as artificial ones. These ac-
tivation domains are modular and can be effective when
removed from one context and transplanted onto other
DNA binding molecules [10,11].
The yeast two-hybrid system exploits this modular fea-
ture of transcriptional activators [12,13]. Several variants
of this general approach have been devised that employ
DNA-binding domain and activation domain fusion pro-
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teins to assess and/or recover proteins that interact. The
exceptional flexibility and efficiency of this system pro-
pelled it to the forefront of protein interaction studies
[14–16]. The technology has also been adopted for a va-
riety of other applications including protein-RNA inter-
actions, small-molecule screens, and screens for random
peptide aptamers [13,17–19].
In this study we used the DNA-binding domain of a lexA
yeast two-hybrid construct to recover short peptides
from random peptide libraries which function as tran-
scriptional activators. A deliberate search for activator
peptides revealed that, although C-terminal peptide fu-
sions to the lexA DNA binding domain had a higher
probability of activating transcription, sequences insert-
ed within the structure of a green fluorescent protein
(GFP) scaffold also functioned as activators. The selected
peptide activators were strongly biased in amino acid
composition compared to unselected library peptides.
However, structural features such as acidity observed in
previous studies were not absolute requirements for ac-
tivation [11,20,21]. Charge neutral and basic peptide ac-
tivators arose at significant frequencies. A peptide 11
residues in length was modular, remaining a competent
activator when grafted into a new context. These results
are consistent with the recruitment model for transacti-
vation and suggest that peptides may act as bridging
molecules [3]. Such short peptidic sequences that acti-
vate transcription may be useful in the context of drug
discovery.
Results
Construction of lexA binding domain peptide libraries
Two random peptide libraries were used in the experi-
ments, one that displayed peptides within the green flu-
orescent protein (GFP) structure, the other as C-terminal
fusions to lexA. The GFP internal random peptide library
was fused to the lexA DNA-binding domain, constructed
according to a method used previously [22] (Figure 1).
Each clone contained a different random peptide se-
quence inserted within a loop located 157 amino acids
from the N-terminus which connects two of the beta
strands of GFP. Thus, the peptides were constrained at
either end by the structure of GFP. A library of 8 million
random peptides of length 15 was created in a yeast ex-
pression vector consisting of a 2µ circle origin, a selecta-
ble marker, and the yeast ADH1 promotor driving
expression of the hybrid proteins.
Even though the library was biased at the DNA level to
avoid stop codons (see Methods), roughly one third of
the clones were expected to contain in-frame stop codons
within the insert, thus producing a truncated GFP mole-
cule containing only the first 157 amino acids of GFP fol-
lowed by C-terminal peptides of variable length up to 15
amino acids. At least some of these truncated products
were expressed at high levels in yeast when fused to lexA
(Caponigro, unpublished). The characteristics of the li-
brary sequences have been described previously [22]. No
dramatic sequence biases were present.
A second library in which 15 residue-long random pep-
tides were fused to the C-terminus of the lexA binding
domain was also constructed. This library was expressed
from a vector that contained a centromere, a selectable
marker, and the ADH1 promotor to drive expression.
Again, the library inserts were biased against stop co-
dons as for the internal peptide library. Sequence analy-
sis of a random set of 71 clones revealed an average C-
terminal peptide sequence length of 11.7 residues, with
no discernible bias for or against particular amino acids
(Table 1).
Isolation of lexA-peptide activators
To select for peptide activators, the lexA-GFP/peptide
and lexA-peptide libraries were introduced separately
into yeast cells and plated on selective media. Only cells
that contained plasmids which activated expression of
the lexA-regulated LEU2 marker grew. The reversion
rate for the assay was low (< 0.001%). Based on the
number of colonies per plate, frequencies of 0.02% of ac-
tivating peptides in the lexA-GFP/peptide library and
0.1% in the C-terminal library were calculated.
Plasmid DNA from 131 individual lexA-GFP/peptide col-
onies and 81 lexA-peptide colonies was recovered and in-
Figure 1
Cartoon of peptide libraries fused to lexA molecules. +GPF
is a truncated GFP molecule of 157 amino acids. CAS is the
11-residue core activating sequence (see Results).BMC Molecular Biology 2001, 2:10 http://www.biomedcentral.com/1471-2199/2/10
sert DNA sequences obtained. For the lexA-GFP/pep
library, these sequences condensed to 44 unique se-
quences with only 9 sequences present in one copy (Ta-
ble 2). The remaining clones (35) were observed multiple
times; one sequence was seen 16 times (not shown). This
suggests that the total population of unique sequences
was relatively small. Retests of individual clones revealed
that ~90% were bona fide activators. For the lexA-pep-
tide library, only 11 were observed multiple times, leav-
ing 55 single observations and a total of 66 unique
sequences. Retests confirmed 100% (16/16) as true acti-
vators.
Analysis of peptide activator sequences
Statistical analysis of the activator peptide sequences
from both libraries demonstrated biases in amino acid
composition and net charge. The frequency of amino ac-
ids among the sequences was skewed significantly to-
ward acidic residues (Table 1). For the lexA-GFP/peptide
library, the ratio of acidic residues to basic residues (D +
E)/(K + R) was about two (63/32). When the net charge
(assuming D = E= -1, K = R = +1) was calculated for the
27 sequences, a highly significant bias in charge distribu-
tion was detected (Figures 2,3,4). The preponderance of
negatively charged sequences exceeded that of positively
charged ones by a factor of about 2 (15 vs. 8). However,
one clone, recovered 2 times and confirmed as an activa-
tor in plasmid linkage tests, had a net charge of +3, and
there was no significant trend toward increased acidity
among the more frequent clones (not shown). For the
lexA-peptide activator set, the distribution was even
more skewed. Negatively charged sequences exceeded
positive ones by a factor of 5 (45 vs. 9). If the C-terminal
negative charge was included, the disparity was over 6-
fold. The (D + E)/(K + R) ratio for this sequence set was
about 4 (127/31). However, there were basic sequences
among the set. For example, of the 16 sequences con-
firmed to have transcriptional activator activity by plas-
mid linkage tests, one was charge neutral and 2 were
basic (+2 and +1; Table 3). Compared with amino acid
frequencies among the unselected lexA-peptide library
sequences, there was a highly significant increase among
activators of glutamate, leucine, phenylalanine and tryp-
tophan (p << 0.001). Arginine was significantly under-
represented. A bias against short peptides with stop co-
dons that terminate translation before the 15 residue
limit is reached was observed among the lexA-peptide
activators. The mean length of activators was 15.1 amino
acids compared to a length of 11.7 in the unselected pop-
ulation.
Table 1: Breakdown of amino acid composition. "p" is the conventional p value for the difference between the observations of amino 
acids among Activators and Random sequences, assuming that the expected variance for the difference is the sum of the Poisson vari-
ances for the number of observations. "P" is the probability that the occurrence frequency would have been observed by chance, given 
the sample size of 20 amino acids (i.e., P = (1 - (1 - p)20)).
LexA-GFP/peptide LexA-peptide
Amino Acid Random Activators p P Random Activators p P
A 14 38 0.000 0.009 55 52 0.386 1.000
C 9 25 0.003 0.059 25 31 0.211 0.991
D 11 62 0.000 0.000 27 86 0.000 0.000
E 10 46 0.000 0.000 16 31 0.014 0.251
F 10 20 0.034 0.499 23 83 0.000 0.000
G 45 68 0.015 0.265 45 39 0.256 0.997
H 6 9 0.219 0.993 36 32 0.314 0.999
I 5 10 0.098 0.874 38 43 0.289 0.999
K 7 9 0.309 0.999 14 11 0.274 0.998
L 19 47 0.000 0.006 71 124 0.000 0.001
M 7 10 0.233 0.995 14 13 0.424 1.000
N 13 11 0.342 1.000 34 38 0.319 1.000
P 10 23 0.012 0.212 83 79 0.377 1.000
Q 4 11 0.035 0.513 27 28 0.446 1.000
R 21 32 0.065 0.741 67 20 0.000 0.000
S 20 43 0.002 0.037 79 92 0.160 0.969
T 10 23 0.012 0.212 60 54 0.287 0.999
V 21 40 0.007 0.140 42 34 0.179 0.981
W 8 26 0.001 0.020 16 49 0.000 0.000
Y 8 13 0.138 0.948 32 48 0.037 0.528
# Sequences 21 44 71 66
# Residues 258 566 831 997BMC Molecular Biology 2001, 2:10 http://www.biomedcentral.com/1471-2199/2/10
We also analyzed the activator sequences from the lexA-
GFP/peptide library which encoded truncated GFP se-
quences. Based on their frequency in the non-selected li-
brary, stop codons were expected at a rate of 27%. Of the
44 unique sequences 32% (14/44) contained stop codons
within the random peptide sequence. Thus, there was
neither a bias toward nor against truncated GFP mole-
cules arising from insert stop codons in this population
of activators. However, 48% (21/44) of unique activator
sequences resulted in truncated GFP due to +1 or -1
frameshift alterations within the random oligonucle-
otide. Both the +1 and -1 frames hit stop codons in GFP
within 10 amino acids of the random peptide sequence.
Furthermore, from the total set of 44 unique sequences,
~39% were +1 frameshifted. When two sequences with
+1 frameshifted inserts were picked from the unselected
random peptide library, both behaved as activators (not
shown). Together, these results suggest that translation
of the +1 frame of GFP, after the random peptide insert,
results in a molecule with activator properties.
Modularity of a peptide activator
One of the peptide activators from the lexA-GFP/peptide
library, derived from a frameshift in the insert, was test-
ed for its ability to activate transcription when separated
from the GFP structure and directly fused to the lexA
binding domain. This sequence, termed Core-Activating
Sequence (CAS), contained 11 amino acids (WS-
FWIQEWNQS), had a net charge of -1, and three tryp-
tophan residues. Five of the amino acids were
contributed by out-of-frame translation of GFP, one
from the random peptide sequence, and 5 from the 3'
linker used to insert the random oligonucleotides for li-
brary construction. An expression construct was tested
along with controls for its ability to activate transcription
of LEU2. In a selection for the LEU2+ phenotype, rough-
ly equivalent numbers of colonies formed on plates for a
lexA-Gal4 control activator protein and for the grafted
peptide. Furthermore, cell patches revealed a level of
growth similar to the Gal4 control (Figures 5 and 6).
Thus, CAS was as potent a transcriptional activator as
Gal4 in this growth assay.
Table 2: Summary of sequence analysis.
Library Activator 
Frequency
Total Analyzed Single Multiple
LexA-GFP/peptide 0.02% 131 9 35
LexA-peptide 0.1% 81 55 11
Figure 2
Graph of net charge of lexA-GFP/peptide activator
sequences. Charge is calculated assuming that D = E = -1, K
= R = +1. Ordinate is the fraction of sequences with a given
charge.
Figure 3
Graph of net charge of lexA-peptide activator sequences (as
in Figure 2).
Figure 4
Bargraph of sequence features displayed by random library
clones vs. activator sequences.BMC Molecular Biology 2001, 2:10 http://www.biomedcentral.com/1471-2199/2/10
Discussion
In general, native transactivating domains are relatively
large, dozens of amino acids in length. However, frag-
ments of native activator proteins have been described.
An 11-amino-acid-long acidic domain from the RelA sub-
unit of NFκ -B is capable of minimal activating behavior
when fused to the Gal4 DNA-binding domain (Gal4BD)
[23]. The sequence, when joined together in tandem ar-
rays, is as potent as the wild type RelA transactivator. Wu
et al. showed that fragments of the Gal4 activation region
between 17 and 41 amino acids in length provide activa-
tion functions of a magnitude in rough proportion to
their length [24]. This result suggests that short sequenc-
es are capable of stimulating transcription when com-
plexed with promotor elements and that their effect is
amplified by increasing the total content of such short se-
quences.
A series of papers has explored properties of random se-
quences, including random peptides, fused to DNA bind-
ing domains in the context of transcriptional activation
assays similar to those used in the two-hybrid system.
Ma and Ptashne isolated a set of E. coli DNA fragments
that, when fused to Gal4BD, promote transcription [11].
Table 3: Retested peptide activator sequences. GFP and linker sequences are not included in the lexA-GFP/peptide activator sequences. 
The asterisk signifies a translational stop; other sequences continue through GFP.
Library Sequence Net Charge No. Occurrences
LexA-GFP/peptide EDDDEFSLWDSML* -6 8
DWDYGIAFDNLGDL* -4 4
EMLFTGLECGPGCEDW -4 4
DCVAACDPVLDWDW -4 3
HDSGLDDRMFADSEPW -4 2
DCEGFPGYASDDNGQG -4 2
VDDVVPEGDPG -4 2
WLWDEDMRDLFQ* -3 11
PTWPDSDITFWD* -3 3
DGSYGPAWLEECLGT -3 2
AWNSVEWGAEDFF* -3 2
RQADDWFDEPGPAG -3 2
DSLDVSLADG -3 2
YYVPTGEDSSD -3 2
GSHSGAMDEYEAWCS -3 2
TVAVGQSWDDFLV* -2 2
GVGSTRSGPSDDNADW -2 3
FDPCDFLRFPTSEAC -2 3
VTWWMGKFNGVLCLG +1 5
KVKEFNSGGVTVCVL +1 4
VFRSCTRHSHCII* +2 4
VVPGLVRVIAHARVL +2 2
SVVPRTRTICRGVQA +3 2
LexA-peptide WESDIWMNSLPWIED* -4 4
QDDFIDVSFDLLYTD* -5 2
GAQDNMLDLFDCTLF* -3 1
DMQYGIDWAADLCLH* -3 1
DFMDLYTRILDCSDQ* -3 1
TFPLLHETDFWAYPY* -2 2
AFSPGLSDSTWWDLI* -2 2
INFDPSLIYSCPWCGE* -2 1
DVASTFEWLLPSHFG* -2 1
NLYSYILEAFTSHVL* -1 1
NDYWNLGSQLALAQF* -1 4
VYFTDAMIGHWSLFP* -1 1
QLIPDPVPFSDFCSYLNK* -1 1
PPTWVPALAWLHGCI* 01
NSHPLNHPRTTLLFF* +1 2
RHRLFVPSLFDLHR* +2 1BMC Molecular Biology 2001, 2:10 http://www.biomedcentral.com/1471-2199/2/10
All (15/15) active sequences examined by the authors en-
code predicted polypeptides that are acidic, and a pep-
tide as small as 12 amino acids was seen. One sequence
(B42), 72 residues long, was shown to function as an ac-
tivator when transferred to the lexA DNA binding do-
main. Yang et al. serendipitously discovered among a set
of retinoblastoma-binding peptides three activators of
length 16 residues that function as Gal4BD C-terminal
fusions [20]. All three are acidic, with charge -3 or -4.
Giniger and Ptashne found that a designed acidic, am-
phipathic alpha helix of 15 amino acids activates tran-
scription when fused to the Gal4BD [10]. Using in vitro
transcription assays, Gerber et al. demonstrated that
homopolymeric stretches as short as 10 residues of
glutamine or proline fused to the Gal4BD function as ac-
tivators [25]. Finally, Lu et al. screened for C-terminal
Gal4BD peptides, 8 amino acids long. Only one basic res-
idue was observed among the set of activator peptides,
and no peptide had a net predicted positive charge [21].
An NMR structure for the lexA DNA-binding domain has
been presented [26]. The structure is compact and glob-
ular, and probably interferes only minimally with fused
transactivating sequences. In addition, the success of the
yeast two-hybrid technique suggests that the geometric
constraints on transactivation are not severe (i.e., the
DNA-binding elements and the transactivating portion
of the molecule (or complex) do not require precise posi-
tioning with respect to each other). Because Gal4-GFP
fusions are unstable, we were unable to analyze the GFP/
peptide insertions identified in the lexA hybrid proteins
in the context of the Gal4BD (not shown). However, a
peptide selected in the context of the amino terminal
portion of GFP functioned effectively when this GFP seg-
ment was removed and the peptide was grafted directly
onto lexA. Due to differences in expression levels among
C-terminal and internal GFP peptide constructs, we did
not consider it useful to pursue more quantitative trans-
activation studies [22,27].
Activator peptides were present in the two libraries at re-
markably high frequencies – 10-3 in the case of the C-ter-
minal library, approximately the same frequency
observed by Lu et al. [21]. The 5-fold lower frequency of
activators in the lexA-GFP/peptide library may indicate
a role for the C-terminal negative charge, the specific ge-
ometry, or the conformational flexibility of the fused (vs.
inserted) peptides. Considerably more than half of the
activator sequences we observed had a large excess of
negative charge, a finding that is consistent with the in-
volvement of acidic residues in the activation process
[11]. However, we observed several examples of charge
neutral and basic peptides (Table 3). As a group, the se-
quences did not display obvious patterns of amphipathic
helicity based on the lack of 3, 4 or 7 repeat units.
Glutamine and proline residues were not significantly
over-represented in the sequence set. Instead, in addi-
tion to glutamate, large hydrophobic amino acids were
abundant. This result accords with mutagenesis experi-
ments that have pinpointed acidic residues and phenyla-
lanine as special contributors to transactivation [23,28].
Two questions are raised by our and other studies of pep-
tide activators: (i) what is the minimum size of an activa-
tor? and, (ii) what is the significance of the extreme
sequence diversity evidenced by transactivating pep-
tides? We identified and tested an 11-residue-long acti-
vator that functioned in two different contexts: at the C-
terminus of a truncated GFP molecule and attached di-
rectly to lexA. Because we did not direct our screen at
smaller peptides, we suspect that a deliberate effort to
identify smaller activators would be fruitful. Indeed, Lu
et al. found 8-mer activators, though none was tested for
modularity [21]. Nonetheless, the tendency for C-termi-
nal activators to be longer than the average library pep-
Figure 5
Bar graph showing results of colony formation assay. 250
yeast cells were plated on leu+ plates and leu-plates and
grown at 30°C for two days. The fraction of cells that
formed colonies on a leu-plate compared to a leu+ plate is
plotted.
Figure 6
Comparison between native activation domain and activator
peptide. Patches of yeast cells on a selection (leu-) plate.BMC Molecular Biology 2001, 2:10 http://www.biomedcentral.com/1471-2199/2/10
tide suggests a preference for length in the
transactivation function [24].
The recruitment model for transcriptional activation
stipulates that eukaryotic transcription is driven mainly
by recruitment of preformed RNA polymerase holoen-
zyme to specific sites on the DNA [3]. According to this
model, peptides may bind one of numerous proteins that
guide holoenzyme to the lexA binding site. Such proteins
include components of holoenzyme and perhaps other
factors [see ref. [3]]. Short peptides can bind proteins
with reasonably high affinity (see ref. [28], for review).
Because transactivation is a process that involves pro-
tein-protein interactions, it is not surprising that pep-
tides linked to DNA-binding domains function as
transactivators by bridging interactions that promote
transcription.
The wide range of primary sequences and sequence fea-
tures described to date among peptide activators sup-
ports the recruitment model. Given the diversity of
proteins that comprise holoenzyme, this model implies
that many sequences of different types would be compe-
tent activators; their sole requirement would be to bind
proteins within holoenzyme [3]. The acidic peptides may
interact in a manner akin to native activators [7]. But the
basic ones may, for example, bind other proteins that
contain acidic regions, thereby forming a bridge to
holoenzyme. Alternatively, these basic peptides may
bind different regions of the holoenzyme component(s)
recognized by acidic peptides, or entirely different subu-
nits [21].
Apart from scientific interest, these findings may have
value in creating tools for drug and drug target discovery
using the yeast two-hybrid system. Isolation of a panel of
small peptides with different structural properties could
improve the performance of the system by providing an
option for multiple screens using a variety of peptides.
This option might decrease false negatives and false pos-
itives if applied intelligently. For example, a series of
positively charged, negatively charged and neutral pep-
tides may enhance the accuracy of the method. In addi-
tion, short activating sequences may prove useful in the
context of isolating peptides that interact with other pro-
teins. Peptides that bind specific proteins of therapeutic
interest in the yeast two-hybrid system have a variety of
applications in drug development. These peptides could
be used as lead-ins for creation of peptido-mimetics. Al-
ternatively, they might provide reagents for high-
throughput displacement screens [30]. Typically, such
peptides are isolated from libraries on the activation do-
main of the two hybrid system [12]. By substituting small
pepticals for the activation function, it may be possible to
define binding sites with higher resolution in the context,
for instance, of the reverse two-hybrid approach [18];
Caponigro et al., unpublished). Small peptides active in
the yeast two-hybrid system may be synthesized by Mer-
rifield procedures, labeled, and used directly in screens
for small molecules [30]. This approach might avoid la-
borious testing of hybrid protein/peptides to determine
which peptides bind independent of their fusion partner.
Finally, non-peptidic molecules that bind in a sequence-
specific manner to DNA have been fused to 20- and 16-
residue peptides. These hybrid molecules activate tran-
scription [9,31]. It may be possible to produce small-
molecule activators (or repressors) that bind DNA spe-
cifically, but also activate transcription of adjacent genes
through a non-peptidic, more drug-like moiety.
Conclusions
Peptide activators are recovered from random peptide li-
braries at high frequency. These peptides display signifi-
cant sequence biases toward negative charge. However,
basic activator peptides are also present in the set. These
results are consistent with the recruitment model of
transcriptional activation in eukaryotes and support the
idea that small molecules directed at the transcription
process may prove to be a useful therapeutic strategy.
Materials and Methods
Yeast strain yVT87 (EGY48 (Clontech) MATa, ura3, his3,
trp1, leu2::lexA6op-LEU2) was transformed by the
method of Gietz and Schiestl (Agatep, R., R.D. Kirk-
patrick, D.L. Parchaliuk, R.A. Woods, and R.D. Gietz
(1998) Transformation of Saccharomyces cerevisiae by
the lithium acetate/single-stranded carrier DNA/poly-
ethylene glycol (LiAc/ss-DNA/PEG) protocol. Technical
Tips Online  [http://tto.trends.com] .). Plasmids were
maintained by growth in standard selective media.
pVT560 was constructed by first filling the BamHI and
XhoI sites in pEG202 (Gyuris et. al (1993), Cell 75:791-
803) with Klenow fragment. The resulting vector was di-
gested with EcoRI, dephosphorylated with calf intestinal
phosphatase (CIP, NEB), and a PCR product generated
from pVT27 (Abedi et. Al, 1998) that contained a version
of the GFP gene modified to have Xho1 and BamHI sites
located between codons specifying N157 and K158, and
EcoRI ends subsequently inserted. Lastly an ~1 kb
"stuffer" fragment containing most of the STE4 gene was
inserted into the XhoI and BamHI sites to aid in purifi-
cation of doubly digested pVT560.
The lexA-GFP/peptide library (lVT560) was created with
oligos oVT335 (TCGAGAGTGCAGGT (NN (G/C/T))15
GGAGCTTCTG), oVT336 (ACCTGCACTC), and oVT337
(GATCCAGAAGCTCC) in the manner described in (Abe-
di et. al, 1998). LVT560 is comprised of roughly 1.2 ×  107,BMC Molecular Biology 2001, 2:10 http://www.biomedcentral.com/1471-2199/2/10
independent clones, of which ~66% contain peptide-en-
coding inserts as judged by restriction digest analysis.
The lexA-peptide library was created in a similar manner
to the lexA-GFP/peptide library except that the sequence
downstream of the random insert contained stop codons
in all three reading frames. A total of 1.5 ×  106 independ-
ent clones (of which over 95% contain random peptides)
were selected to indentify transcriptionally active pep-
tides.
pVT725 was created by replacing the ampicillin resist-
ance cassette on pLexA (Clontech) with a kanamycin re-
sistance gene (obtained from pGBKT7 (Clontech) by
PCR) via homologous recombination in yeast.
The CAS peptide was transferred to pLexA as follows:
Two complementary oligos which encoded the 11 amino
acid CAS peptide (oVT2899: AATTCTGGAGCTTCT-
GGATCCAAGAATGGAATCAAAGTTAAG, and
oVT2900: GGCCGCTTAACTTTGATTCCATTCTT-
GGATCCAGAAGCTCCAG) were annealed in PCR buffer
and cloned using standard methods into pVT725 via
EcoRI and NotI restriction sites. This resulted in the fu-
sion of the CAS peptide onto the C-terminus of lexA.
Transcriptionally active peptides were selected by trans-
forming yVT87 with the appropriate peptide library and
selecting for transformants on plates lacking histidine.
Transformants were then pooled and transferred onto
plates lacking histidine and leucine in order to select for
peptide sequences capable of activating the lexA-opera-
tor-driven LEU2 reporter. DNA encoding peptides of in-
terest was amplified by PCR using oligos flanking the
insert and sequenced using an ABI 377 automated DNA
sequencer (Applied Biosystems). Plasmids were retested
by isolation from yeast using the phenol/glass bead
method followed by electroporation into bacteria [32].
The plasmids were then isolated from bacteria using a
commercial DNA miniprep kit (Qiagen) and re-trans-
formed in to yVT87.
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